The Effect of HIV Tat Protein on HCV Replication in an In-vitro Model System

Completed

Conditions studied: Human Immunodeficiency Virus (HIV), Hepatitis C, Chronic

In brief

Investigators in the Division of Infectious Diseases and the Departments of Biochemistry and Molecular Biology of The George Washington University Medical Center are carrying out a research study to determine why patients with Human Immunodeficiency Virus (HIV) and Hepatitis C virus (HCV) co-infection (HIV/HCV) have a more rapid and progressive course of HCV infection, leading to fatty infiltration of the liver and cirrhosis.

Key facts

Study ID

NCT01206933

Run by

George Washington University

People needed

20

Starts

2010-07-01

Expected to finish

2015-06-01

Last updated by the study team

2016-02-10

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Meets one of the following criteria:
• detectable HIV RNA and detectable HCV RNA
• undetectable HIV RNA (treated) and detectable HCV RNA
• undetectable HIV RNA (treated) and undetectable HCV RNA
• undetectable HCV RNA (mono-infected)
• detectable HCV RNA (mono-infected)
• detectable HIV RNA (mono-infected)
• Participants will be men and women, ages 18 and older, and who are patients being seen in the clinics of the Medical Faculty Associates, and meet the above criteria.

You may not qualify if…

• None

Where it is running

• George Washington University Medical Faculty Associates — Washington D.C., District of Columbia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.